Printer Friendly

PHARMACEUTICAL RESOURCES' SUBSIDIARY TERMINATES AGREEMENT

 PHARMACEUTICAL RESOURCES' SUBSIDIARY TERMINATES AGREEMENT
 SPRING VALLEY, N.Y., April 15 /PRNewswire/ -- Pharmaceutical Resources, Inc. (NYSE: PRX), announced today that its subsidiary, Quad Pharmaceuticals, Inc., has terminated its letter of intent with T&S Holding, Inc., pertaining to the sale of substantially all of Quad's assets to T&S. The company said that it is continuing to pursue other alternatives that it has identified with respect to the disposition of Quad and/or its assets.
 -0- 4/15/92
 /CONTACT: Richard J. Nadler or Michael A. Swit of Pharmaceutical Resources, 914-425-7100/
 (PRX) CO: Pharmaceutical Resources, Inc. ST: New York IN: MTC SU: TNM


SM-TQ -- NY095 -- 8823 04/15/92 15:08 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Apr 15, 1992
Words:112
Previous Article:PONTIAC BONNEVILLE SE SELECTED 'BEST AMERICAN SEDAN' BY MOTORWEEK
Next Article:F&M FINANCIAL SERVICES ANNOUNCES FIRST QUARTER EARNINGS


Related Articles
PHARMACEUTICAL RESOURCES ANNOUNCES SETTLEMENT OF FINAL ASPECT OF SHAREHOLDER LAWSUITS
PAR PHARMACEUTICAL REACHES AGREEMENT WITH NEW YORK STATE
PAR PHARMACEUTICAL NOW ELIGIBLE TO BID ON GOVERNMENT CONTRACTS UNDER AGREEMENT WITH DEFENSE LOGISTICS AGENCY
HEALTH-CHEM REPORTS ON BOLAR VS. HERCON LITIGATION
PHARMACEUTICAL RESOURCES EXPECTS TO EXPAND DISTRIBUTION ARRANGEMENTS
FUJISAWA USA. INC. FILES DECLARATION JUDGEMENT ACTION AGAINST MEDCO RESEARCH INC.
PHARMACEUTICAL RESOURCES, INC. ANNOUNCES SETTLEMENT OF LAWSUIT WITH MYLAN LABORATORIES, INC.
PHARMACEUTICAL RESOURCES ANNOUNCES SETTLEMENT OF LAWSUIT WITH MINNESOTA MINING & MANUFACTURING ("3M")
PHARMACEUTICAL RESOURCES, INC. ANNOUNCES EXCLUSIVE U.S. LICENSING AGREEMENT FOR THE DISTRIBUTION OF GENERIC TRANSDERMAL PRODUCTS
COOPERSURGICAL DISCONTINUES FUNDING OF INNERDYNE'S THERMAL ENDOMETRIAL ABLATION TECHNOLOGY

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters